Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Clasificación en acciones #39281
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Precio por acción
$2.06
Última sincronización: 2026-08-11
Capitalización bursátil
$572.30K
Cambio (1 día)
0.00%
Cambio (1 año)
-90.38%
País
CA
Comercio XORTX Therapeutics Inc. (XRTX)

Categoría

Historial de rendimiento por dividendo de XORTX Therapeutics Inc. (XRTX)
Rendimiento por dividendo (TTM) de XORTX Therapeutics Inc. (símbolo bursátil: XRTX) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de XORTX Therapeutics Inc. (XRTX) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.65%
BE